These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 27339444)

  • 21. Impact of severity of renal dysfunction on determinants of in-hospital mortality among patients undergoing percutaneous coronary intervention.
    Parikh PB; Jeremias A; Naidu SS; Brener SJ; Lima F; Shlofmitz RA; Pappas T; Marzo KP; Gruberg L
    Catheter Cardiovasc Interv; 2012 Sep; 80(3):352-7. PubMed ID: 22566286
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Health-Related Quality of Life Impacts Mortality but Not Progression to End-Stage Renal Disease in Pre-Dialysis Chronic Kidney Disease: A Prospective Observational Study.
    Jesky MD; Dutton M; Dasgupta I; Yadav P; Ng KP; Fenton A; Kyte D; Ferro CJ; Calvert M; Cockwell P; Stringer SJ
    PLoS One; 2016; 11(11):e0165675. PubMed ID: 27832126
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of IL-6 and a functional polymorphism in the IL-6 gene with cardiovascular events in patients with CKD.
    Spoto B; Mattace-Raso F; Sijbrands E; Leonardis D; Testa A; Pisano A; Pizzini P; Cutrupi S; Parlongo RM; D'Arrigo G; Tripepi G; Mallamaci F; Zoccali C
    Clin J Am Soc Nephrol; 2015 Feb; 10(2):232-40. PubMed ID: 25492254
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association between prevalence of laxative use and history of bone fractures and cardiovascular diseases in patients with chronic kidney disease: the Fukuoka Kidney disease Registry (FKR) study.
    Yamada S; Tanaka S; Arase H; Hiyamuta H; Kitamura H; Tokumoto M; Mitsuiki K; Tsuruya K; Kitazono T; Nakano T
    Clin Exp Nephrol; 2023 Feb; 27(2):151-160. PubMed ID: 36318395
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outcomes of stage 1-5 chronic kidney disease in Mainland China.
    Lai X; Zhang AH; Chen SY; He L; Su CY; Fan MH; Wang T
    Ren Fail; 2014 May; 36(4):520-5. PubMed ID: 24456114
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A contemporary evaluation of carotid endarterectomy outcomes in patients with chronic kidney disease in the United States.
    Patel AR; Dombrovskiy VY; Vogel TR
    Vascular; 2017 Oct; 25(5):459-465. PubMed ID: 28181855
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Chronic Renal Insufficiency Cohort (CRIC) Study: Design and Methods.
    Feldman HI; Appel LJ; Chertow GM; Cifelli D; Cizman B; Daugirdas J; Fink JC; Franklin-Becker ED; Go AS; Hamm LL; He J; Hostetter T; Hsu CY; Jamerson K; Joffe M; Kusek JW; Landis JR; Lash JP; Miller ER; Mohler ER; Muntner P; Ojo AO; Rahman M; Townsend RR; Wright JT;
    J Am Soc Nephrol; 2003 Jul; 14(7 Suppl 2):S148-53. PubMed ID: 12819321
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [REIN Report 2011--summary].
    Couchoud C; Lassalle M; Jacquelinet C
    Nephrol Ther; 2013 Sep; 9 Suppl 1():S3-6. PubMed ID: 24119584
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association between chronic kidney disease progression and cardiovascular disease: results from the CRIC Study.
    Rahman M; Xie D; Feldman HI; Go AS; He J; Kusek JW; Lash J; Miller ER; Ojo A; Pan Q; Seliger SL; Steigerwalt S; Townsend RR;
    Am J Nephrol; 2014; 40(5):399-407. PubMed ID: 25401485
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Epidemiology of chronic kidney disease].
    Noël D; Landais P
    Rev Prat; 2012 Jan; 62(1):38-42. PubMed ID: 22335065
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chinese observational prospective study of ageing population with chronic kidney disease (C-OPTION): a study protocol.
    Liang S; Wang WL; Zhu FL; Duan SW; Sun XF; Chen XM; Cai GY;
    BMJ Open; 2018 Feb; 8(2):e019457. PubMed ID: 29478020
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term mortality and risk factors for development of end-stage renal disease in critically ill patients with and without chronic kidney disease.
    Rimes-Stigare C; Frumento P; Bottai M; Mårtensson J; Martling CR; Bell M
    Crit Care; 2015 Nov; 19():383. PubMed ID: 26526622
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epidemiology of CKD Regression in Patients under Nephrology Care.
    Borrelli S; Leonardis D; Minutolo R; Chiodini P; De Nicola L; Esposito C; Mallamaci F; Zoccali C; Conte G
    PLoS One; 2015; 10(10):e0140138. PubMed ID: 26462071
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum β-Trace Protein and β2-Microglobulin as Predictors of ESRD, Mortality, and Cardiovascular Disease in Adults With CKD in the Chronic Renal Insufficiency Cohort (CRIC) Study.
    Foster MC; Coresh J; Hsu CY; Xie D; Levey AS; Nelson RG; Eckfeldt JH; Vasan RS; Kimmel PL; Schelling J; Simonson M; Sondheimer JH; Anderson AH; Akkina S; Feldman HI; Kusek JW; Ojo AO; Inker LA;
    Am J Kidney Dis; 2016 Jul; 68(1):68-76. PubMed ID: 26948990
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biomarkers in native and transplant kidneys: opportunities to improve prediction of outcomes in chronic kidney disease.
    De Serres SA; Varghese JC; Levin A
    Curr Opin Nephrol Hypertens; 2012 Nov; 21(6):619-27. PubMed ID: 22914685
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Body mass index has no effect on rate of progression of chronic kidney disease in subjects with type 2 diabetes mellitus.
    Mohsen A; Brown R; Hoefield R; Kalra PA; O'Donoghue D; Middleton R; New D
    J Nephrol; 2012; 25(3):384-93. PubMed ID: 22241634
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Healthy lifestyle and risk of kidney disease progression, atherosclerotic events, and death in CKD: findings from the Chronic Renal Insufficiency Cohort (CRIC) Study.
    Ricardo AC; Anderson CA; Yang W; Zhang X; Fischer MJ; Dember LM; Fink JC; Frydrych A; Jensvold NG; Lustigova E; Nessel LC; Porter AC; Rahman M; Wright Nunes JA; Daviglus ML; Lash JP;
    Am J Kidney Dis; 2015 Mar; 65(3):412-24. PubMed ID: 25458663
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute Kidney Injury: Tubular Markers and Risk for Chronic Kidney Disease and End-Stage Kidney Failure.
    Tan HL; Yap JQ; Qian Q
    Blood Purif; 2016; 41(1-3):144-50. PubMed ID: 26764483
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rationale and study design of a randomized controlled trial to assess the effects of maintaining hemoglobin levels using darbepoetin alfa on prevention of development of end-stage kidney disease in non-diabetic CKD patients (PREDICT Trial).
    Imai E; Maruyama S; Nangaku M; Hirakata H; Hayashi T; Narita I; Kono H; Nakatani E; Morita S; Tsubakihara Y; Akizawa T
    Clin Exp Nephrol; 2016 Feb; 20(1):71-6. PubMed ID: 26081567
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Renal outcomes in chronic kidney disease.
    Iseki K
    Nephrology (Carlton); 2010 Jun; 15 Suppl 2():27-30. PubMed ID: 20586944
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.